Nr

Test before launch: Japan’s DHC Corp to study NMN’s benefits for sleep, beauty-from-within

11-Apr-2023 By Tingmin Koe

Japan’s cosmetics and health supplements firm DHC Corp will be studying the benefits of nicotinamide mononucleotide (NMN) supplementation on sleep and beauty-from-within, the firm told us in an exclusive interview.

NAD+ precursors: Hong Kong, ANZ and China help drive Chromadex results as firm fires warning over NMN explosion

16-Mar-2021 By Tingmin Koe

Nicotinamide riboside (NR) supplement specialist Chromadex’s has posted strong regional and global FY2020 financials, but the firm has issued a warning of ‘concerning behaviour’ from some nicotinamide mononucleotide (NMN) brands, especially in China.

Combined benefits: NZ's About Health adds multi-ingredient NR product to healthy ageing range

21-May-2020 By Tingmin Koe

New Zealand direct-selling company About Health has added a multi-ingredient nicotinamide riboside (NR)-based product to its existing range of healthy ageing dietary supplements.

ChromaDex’s nicotinamide riboside chloride receives Australia’s TGA ingredient approval

16-Dec-2019 By Guan Yu Lim

ChromaDex has received approval from the Australian Therapeutic Goods Administration (TGA) for use of its patented nicotinamide ribosome chloride (NR) in listed complementary medicines in the country.

Nicotinamide riboside may boost mitochondrial energy production and memory in Alzheimer's Disease

11-Dec-2017 By Stephen Daniells

Nicotinamide riboside, a vitamin B3 derivative, may improve mitochondrial energy production and improve memory, according to a new study on lab mice.